Tops & Flops Stocks
Security ▲ | Change (%) | 1w | 1m | 1y | YTD | 3y | 5y |
---|---|---|---|---|---|---|---|
Acadia Healthcare | 1.460% | 5.303% | -3.472% | 5.303% | -1.418% | 37.624% | 141.823% |
Acadia Pharmaceuticals | 1.450% | 0.807% | -7.604% | -19.510% | -45.018% | -8.738% | -33.849% |
Acceleron Pharma Inc. | - | - | - | - | - | - | - |
Agios Pharmaceuticals Inc. | 3.380% | 7.746% | 15.038% | 50.000% | 48.544% | -34.165% | -39.322% |
Alnylam Pharmace. | 4.380% | 0.372% | -2.565% | -25.497% | -23.814% | 17.261% | 72.685% |
Amedisys Inc. | 0.600% | 0.595% | 0.000% | 18.182% | 0.000% | -63.889% | -23.819% |
Amicus Therapeutics Inc. | -3.550% | -4.040% | -13.636% | -9.524% | -28.571% | 15.152% | - |
Arena Pharmaceuticals Inc | - | - | - | - | - | - | - |
Arrowhead Pharmaceuticals Inc. | 2.590% | -2.528% | -19.932% | -34.028% | -24.680% | -64.954% | 32.150% |
Bio-Techne Corp. | 0.830% | 1.681% | -6.202% | -19.333% | -14.789% | - | - |
Bluebird Bio Inc. | 2.740% | -2.802% | -29.551% | -78.663% | -32.659% | -96.638% | - |
Blueprint Medicines Corp | 13.260% | -0.719% | -2.682% | 84.569% | 3.806% | 6.730% | - |
Bruker Corp. | 1.830% | -4.893% | -16.000% | 1.500% | 9.895% | - | - |
CONMED Corp. | 2.460% | -5.303% | -15.541% | -44.690% | -38.119% | -46.121% | -10.330% |
Davita Inc. | 0.580% | 4.996% | 1.876% | 58.864% | 38.000% | 34.385% | 159.407% |
Ensign Group Inc. | -1.800% | -1.786% | -2.655% | - | 6.796% | - | - |
Exelixis Inc. | -7.870% | -0.722% | 0.091% | 32.350% | 0.503% | 7.373% | 22.849% |
Fibrogen Inc. | -0.330% | -4.944% | -56.606% | -93.776% | 10.000% | -94.900% | - |
Genomic Health | -2.270% | - | - | - | - | - | - |
Global Blood Therapeutics Inc | - | - | - | - | - | - | - |
Halozyme Therapeutics Inc. | 3.000% | - | -2.639% | 25.317% | 7.917% | -12.082% | - |
Healthequity Inc. | -0.680% | 0.000% | -3.289% | 51.235% | 23.529% | 17.262% | - |
Hms Holdings Corp. | -1.270% | - | - | - | - | - | - |
Icu Medical Inc. | 1.110% | 1.111% | -4.211% | -45.833% | 1.676% | -46.784% | -54.962% |
Immunomedics Inc. | - | - | - | - | - | - | - |